Search Results - "Tesfaye, Bekalu Amare"

Targeting Netrin-1 and -4 as a Novel Diagnostic Parameter and Treatment Option for Diabetic Retinopathy by Zewdie, Kaleab Alemayehu, Ayza, Muluken Altaye, Tesfaye, Bekalu Amare, Yimer, Ebrahim M

“…Diabetic retinopathy (DR) is a retinal vascular disorder associated with both type 1 and type 2 diabetes mellitus (DM). It is characterized by specific loss of…”
Get full text

The Role of Antioxidants in Ameliorating Cyclophosphamide-Induced Cardiotoxicity by Wondafrash, Dawit Zewdu, Tesfaye, Bekalu Amare, Zewdie, Kaleab Alemayehu, Ayza, Muluken Altaye, Berhe, Abera Hadgu

“…The chemotherapeutic and immunosuppressive agent cyclophosphamide has previously been shown to induce complications within the setting of bone marrow…”
Get full text

Cardioprotective Effect of Crude Extract and Solvent Fractions of Urtica simensis Leaves on Cyclophosphamide-Induced Myocardial Injury in Rats by Tesfaye, Bekalu Amare, Berhe, Abera Hadgu, Wondafrash, Dawit Zewdu, Berhe, Derbew Fikadu

“…Globally, cardiovascular diseases (CVDs) are becoming the major cause of death. is one of endogenous plant which treats a wide range of disease conditions…”
Get full text

Potential Protective Effects of Antioxidants against Cyclophosphamide-Induced Nephrotoxicity by Ayza, Muluken Altaye, Zewdie, Kaleab Alemayehu, Yigzaw, Elias Fitsum, Ayele, Solomon Gashaw, Tesfaye, Bekalu Amare, Tafere, Gebrehiwot Gebremedhin, Abrha, Muzey Gebreyohannes

“…Cyclophosphamide is an alkylating antineoplastic agent, and it is one of the most successful drugs with wide arrays of clinical activity. It has been in use…”
Get full text

Anti-Diabetic Effect of Telmisartan Through its Partial PPARγ-Agonistic Activity by Ayza, Muluken Altaye, Zewdie, Kaleab Alemayehu, Tesfaye, Bekalu Amare, Gebrekirstos, Selamawit Tesfamariam, Berhe, Derbew Fikadu

“…Telmisartan is an angiotensin II receptor antagonist, which selectively inhibits the angiotensin II type 1 receptor. Thus, it is widely used for hypertension…”
Get full text

Montelukast: The New Therapeutic Option for the Treatment of Epilepsy by Tesfaye, Bekalu Amare, Hailu, Haftom Gebregergs, Zewdie, Kaleab Alemayehu, Ayza, Muluken Altaye, Berhe, Derbew Fikadu

“…Currently, there is no definitive cure for epilepsy. The available medications relieve symptoms and reduce seizure attacks. The major challenge with the…”
Get full text

A Systematic Review on Rho-Kinase as a Potential Therapeutic Target for the Treatment of Erectile Dysfunction by Zewdie, Kaleab Alemayehu, Ayza, Muluken Altaye, Tesfaye, Bekalu Amare, Wondafrash, Dawit Zewdu, Berhe, Derbew Fikadu

“…Erectile dysfunction (ED) is a common clinical condition with limited treatment options. The main aim of the present systematic review was to synthesize…”
Get full text

Anti-Diabetic Effect of Telmisartan Through its Partial PPAR[gamma]-Agonistic Activity by Ayza, Muluken Altaye, Zewdie, Kaleab Alemayehu, Tesfaye, Bekalu Amare, Gebrekirstos, Selamawit Tesfamariam, Berhe, Derbew Fikadu

“…Telmisartan is an angiotensin II receptor antagonist, which selectively inhibits the angiotensin II type 1 receptor. Thus, it is widely used for hypertension…”
Get full text

Antileishmanial Activity of Tamoxifen by Targeting Sphingolipid Metabolism: A Review by Zewdie, Kaleab Alemayehu, Hailu, Haftom Gebregergs, Ayza, Muluken Altaye, Tesfaye, Bekalu Amare

“…Leishmaniasis is a widespread group of neglected parasitic diseases caused by protozoa of the genus . Around 2 million new cases are reported each year and…”
Get full text